Stech Eileen P, Grierson Ashlee B, Chen Aileen Z, Sharrock Maria J, Mahoney Alison E J, Newby Jill M
School of Psychology, University of New South Wales Sydney, NSW 2052, Australia.
Clinical Research Unit for Anxiety and Depression, St Vincent's Hospital, Sydney, NSW 2010, Australia.
Internet Interv. 2020 Mar 19;20:100315. doi: 10.1016/j.invent.2020.100315. eCollection 2020 Apr.
This is the first pilot study to explore the feasibility, acceptability and preliminary efficacy of intensive cognitive behavioral therapy (CBT) for panic disorder and/or agoraphobia delivered via the internet. Ten participants who met DSM-5 criteria for panic disorder and/or agoraphobia (6 males; mean age = 43.40, = 15.25) completed : a six-lesson exposure-based CBT program, delivered online over seven days. Clinician support was provided via phone and email. All 10 participants completed the program (100% adherence) and high levels of satisfaction were reported. We found large and significant reductions in panic symptom severity at post-treatment ( = 1.40), which were maintained at two-month follow-up. We also found large reductions in agoraphobic avoidance ( = 0.92) and functional impairment ( = 1.04) at follow-up, and days out of role were halved. On average, 132 min ( = 42, range: 47-183) of clinician time was spent per participant during the treatment week. The results provide promising preliminary evidence for the feasibility and acceptability of internet-delivered intensive CBT for panic disorder and/or agoraphobia. A larger, randomized control trial is now needed to evaluate the efficacy of this program compared to a control group and to explore long-term outcomes. ACTRN12618001501235.
这是第一项探索通过互联网提供的针对惊恐障碍和/或场所恐惧症的强化认知行为疗法(CBT)的可行性、可接受性和初步疗效的试点研究。10名符合DSM-5惊恐障碍和/或场所恐惧症标准的参与者(6名男性;平均年龄=43.40,标准差=15.25)完成了一项为期7天在线提供的基于暴露的六节课CBT项目。通过电话和电子邮件提供临床医生支持。所有10名参与者都完成了该项目(依从率100%),并报告了较高的满意度。我们发现治疗后惊恐症状严重程度大幅显著降低(标准差=1.40),在两个月的随访中保持稳定。我们还发现随访时场所恐惧回避(标准差=0.92)和功能损害(标准差=1.04)大幅降低,失能天数减半。在治疗周期间,每位参与者平均花费临床医生时间132分钟(标准差=42,范围:47-183)。这些结果为通过互联网提供的针对惊恐障碍和/或场所恐惧症的强化CBT的可行性和可接受性提供了有希望的初步证据。现在需要一项更大规模的随机对照试验来评估该项目与对照组相比的疗效,并探索长期结果。澳大利亚新西兰临床试验注册中心编号:ACTRN12618001501235。